Exhibit 4.3
AGREEMENT IN PRINCIPLE
THIS AGREEMENT IN PRINCIPLE, dated as of January 6, 1998 (this
"Agreement"), by and between NAPRO BIOTHERAPEUTICS, INC., a Delaware corporation
(the "Company"), and ADVANTAGE FUND II, LTD., a British Virgin Islands
corporation (the "Holder").
1. The Company and the Holder agree in principle to a
modification of the terms of the Company's Series C Senior Convertible Preferred
Stock as described on Exhibit A attached hereto.
2. This Agreement is subject to preparation, negotiation,
execution and delivery on or before January 19, 1998 of definitive documentation
setting forth the modifications described on Exhibit A attached hereto on terms
mutually satisfactory to the Company and the Holder and approval of the terms of
such documents by the Boards of Directors or similar persons of the Company and
the Holder.
3. This Agreement shall be governed by and construed in
accordance with the laws of the State of New York applicable to contracts to be
made and performed entirely in the State of New York.
IN WITNESS WHEREOF, the parties hereto have caused this
Agreement to be duly executed by their officers or other representatives as of
the date first set forth above.
NAPRO BIOTHERAPEUTICS, INC.
By: \s\ Xxxxxx X. Link, Jr.
Name:Xxxxxx X. Link, Jr.
Title: Chief Financial Officer
ADVANTAGE FUND II, LTD.
By:/s/
Name:
Title:
8
